XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 29.81

-4.3%

Dec 2 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (16304)	10/3/2003 4:01:05 PM
From: Cacaito	of 17367

Blue, explain to me this: either the Rituxan Royalty buyers were geniuses giving $17M for 100% profit per year for 20 years... ...or xomeone was idiot enough to sell same Royies to put it in the same kind of trial that your links are suggesting so good !!! You know that was the trauma trial, exactly what you are suggesting so great. By the way, I am sure you remember that during the trauma trial bpi was not able to protect against infections, forget inflammation tough part, BUGS were not prevented by the bpi stuff.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next